Yubo International Biotech Limited (YBGJ)

Market Cap	10.78M
Revenue (ttm)	-18.00
Net Income (ttm)	-1.83M
Shares Out	119.82M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	69,500
Average Volume	14,177
Open	0.0900
Previous Close	0.0900
Day's Range	0.0900 - 0.1091
52-Week Range	0.0310 - 1.3700
Beta	0.74
RSI	59.14
Earnings Date	May 15, 2025

About YBGJ

Yubo International Biotech Limited, through its subsidiaries, focuses on the research and development and application of endometrial stem cells in Hong Kong and the People’s Republic of China. The company offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. Yubo International Biotech Limited is headquartered in Beijing, China.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• CEO: Yang Wang
• Employees: 18
• Stock Exchange: OTCMKTS
• Ticker Symbol: YBGJ

Financial Performance

In 2024, YBGJ's revenue was $3,470, a decrease of -99.43% compared to the previous year's $604,676. Losses were -$1.78 million, 48.6% more than in 2023.